Static and dynamic effects of health policy: Evidence from the vaccine industry
Static and dynamic effects of health policy: Evidence from the vaccine industry
复制标题
DOI：
10.1162/0033553041382166
复制
发表时间：
2004-05-01
影响因子：
13.7
通讯作者：
Finkelstein, A
中科院分区：
文献类型：
--
作者：
Finkelstein, A
旨在提高现有技术利用率的公共政策也可能影响对开发新技术的激励。本文通过检查旨在增加现有疫苗使用量的政策来调查这一现象。我发现这些政策与新疫苗临床试验增加2.5倍有关。对于几种疾病来说，引发的创新是对社会的浪费，尽管规模很小。然而，在一个案例中，诱导性创新带来的“动态”社会福利收益超过了现有技术增加疫苗接种带来的政策“静态”收益。这些发现强调了将技术进步纳入公共政策的经济分析的重要性。
Public policies designed to increase utilization of existing technologies may also affect incentives to develop new technologies. This paper investigates this phenomenon by examining policies designed to increase usage of preexisting vaccines. I find that these policies were associated with a 2.5-fold increase in clinical trials for new vaccines. For several diseases, the induced innovation is socially wasteful, though small in magnitude. In one case, however, the "dynamic" social welfare benefits from induced innovation exceed the policies' "static" benefits from increasing vaccination with existing technology. These findings underscore the importance of including technological progress in economic analysis of public policy.